NCT04343339View on ClinicalTrials.gov

Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 8, 2020

Primary Completion Date

July 30, 2020

Study Completion Date

September 30, 2020

Conditions
Addiction, SubstanceCOVID-19
Trial Locations (1)

34295

Uhmontpellier, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT04343339 - Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment | Biotech Hunter | Biotech Hunter